Osaic Holdings’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $161K | Sell |
7,707
-3,957
| -34% | -$82.6K | ﹤0.01% | 3771 |
|
|
2025
Q1 | $239K | Sell |
11,664
-13,636
| -54% | -$279K | ﹤0.01% | 3483 |
|
|
2024
Q4 | $573K | Sell |
25,300
-1,423
| -5% | -$32.2K | ﹤0.01% | 2665 |
|
|
2024
Q3 | $658K | Sell |
26,723
-807
| -3% | -$19.9K | ﹤0.01% | 2618 |
|
|
2024
Q2 | $636K | Sell |
27,530
-38,170
| -58% | -$882K | ﹤0.01% | 2563 |
|
|
2024
Q1 | $1.58M | Buy |
65,700
+16,744
| +34% | +$403K | ﹤0.01% | 1879 |
|
|
2023
Q4 | $1.13M | Buy |
48,956
+3,629
| +8% | +$83.5K | ﹤0.01% | 2397 |
|
|
2023
Q3 | $922K | Sell |
45,327
-917
| -2% | -$18.7K | ﹤0.01% | 2700 |
|
|
2023
Q2 | $1.08M | Buy |
46,244
+176
| +0.4% | +$4.11K | ﹤0.01% | 2447 |
|
|
2023
Q1 | $1.07M | Buy |
46,068
+7,234
| +19% | +$168K | ﹤0.01% | 2384 |
|
|
2022
Q4 | $977K | Buy |
38,834
+21,428
| +123% | +$539K | ﹤0.01% | 2388 |
|
|
2022
Q3 | $459K | Buy |
17,406
+5,829
| +50% | +$154K | ﹤0.01% | 2978 |
|
|
2022
Q2 | $339K | Buy |
11,577
+531
| +5% | +$15.5K | ﹤0.01% | 3318 |
|
|
2022
Q1 | $186K | Buy |
11,046
+479
| +5% | +$8.07K | ﹤0.01% | 4090 |
|
|
2021
Q4 | $463K | Buy |
10,567
+685
| +7% | +$30K | ﹤0.01% | 3141 |
|
|
2021
Q3 | $495K | Sell |
9,882
-114
| -1% | -$5.71K | ﹤0.01% | 3043 |
|
|
2021
Q2 | $523K | Buy |
9,996
+421
| +4% | +$22K | ﹤0.01% | 2991 |
|
|
2021
Q1 | $439K | Buy |
9,575
+6,250
| +188% | +$287K | ﹤0.01% | 3010 |
|
|
2020
Q4 | $153K | Buy |
3,325
+76
| +2% | +$3.5K | ﹤0.01% | 3715 |
|
|
2020
Q3 | $127K | Buy |
3,249
+1,325
| +69% | +$51.8K | ﹤0.01% | 3617 |
|
|
2020
Q2 | $73K | Buy |
+1,924
| New | +$73K | ﹤0.01% | 3904 |
|